GlassScriptPhysician profile
Douglas Toole
NPI 1740543834
$258,388.79
in general payments reported to CMS, 2019-2025
12 companies · $49.75 in 2025
The $49.75 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $187 · 2021: $3,295 · 2022: $3,312 · 2024: $251K · 2025: $49.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $251K · Food and Beverage: $49.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $251,372.00 |
| Food and Beverage | $49.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $251,372.00 | 2024 | |
| Flower Orthopedics Coporation | $6,487.28 | 2020-2022 | |
| Shire North American Group INC | $106.73 | 2019 | |
| Kerecis Limited | $90.54 | 2021 | |
| Imbed Biosciences INC. | $80.91 | 2022 | |
| Medtronic, INC. | $80.79 | 2022 | |
| Abbott Laboratories | $54.50 | 2021 | |
| Solventum Corporation | $31.17 | 2025 | Activ.A.C. |
| Horizon Therapeutics Plc | $30.06 | 2019 | |
| Crossroads Extremity Systems, LLC | $23.49 | 2019 | |
| Amgen INC. | $18.58 | 2025 | Krystexxa |
| Tactile Systems Technology INC | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Toole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.